Objective: To assess the methods and frequency by which medication reviews are performed by general practitioners and nursing home physicians by means of a survey.
Introduction
The rising incidence of multi-morbidity among older people makes polypharmacy a global challenge. The prevalence of multi-morbidity among those 65 years and older has been estimated at 60% worldwide [1, 2] . More than 90% of persons aged 65 years or older use at least one drug per week. Polypharmacy defined as ≥ 5 medicines per person was present in 19% of men and 23% of women aged 65 or older in an ambulatory setting [3] . In 2011 there were 2.6 million inhabitants aged 65 or older in the Netherlands [4] . Assuming similar prevalence to the USA, this would mean that polypharmacy is present in approximately 540.000 of older Dutch patients. In the UK, there are approximately 400.000 older residents living in care homes, which comprise 4% of the UK population aged 65 and over. These residents had a prescription for 7.2 medicines on average [5, 6] . Polypharmacy increases the risk on adverse drug reactions, such as cognitive loss, delirium, falls, fractures, urine-incontinence, renal function loss, haemorrhage, unnecessary hospital-or nursing home admissions, and even death [7] [8] [9] [10] [11] . A Dutch study showed that, of all unplanned hospital admissions, 5.6% were medication-related [10] . Almost half (46.5%) of these admissions were considered to be potentially preventable. The mean age of the patients with a potentially preventable hospital admission was significantly higher (68 years) than the age of the patients with an unplanned admission (60 years). Polypharmacy was one of the main risk factors [10] .
Therefore, adequate medication management is an important cornerstone in the care for older people.
In the Netherlands, daily and long-term medical care for older patients is provided by general practitioners when the patient lives independently in the community or in a residential home. When morbidity and disability are so severe that independent living is no longer possible, they are admitted to a nursing home, where nursing home physicians are responsible for the medical care [12] . In 2012 there were about 365 nursing homes, with approximately 65,000 beds.
According to the Dutch survey of the Health Care Inspectorate:'medication safety for vulnerable groups in long-term care and at home is insufficient', a yearly medication review should be performed for every older person by a physician, pharmacist, nurse, and if possible with the patient him/herself. For nursing home patients the review should be performed twice a year [13] . However, performing medication reviews this way is very time-consuming and demands frequent meetings between physician, pharmacist, nursing staff and the patient. Therefore, it is presumed that these requirements will be hard to meet in daily practice.
Moreover, despite this general advice, it is largely unknown how (and whether) this is practised at present. The aim of this study was to examine the methods and frequency by which medication reviews are performed by general practitioners and nursing home physicians, using a web-based questionnaire.
Methods

Subjects
Nursing home physicians and general practitioners working within the area of postal codes 6211 to 6325, located in the southern part of the province of Limburg, the Netherlands.
Questionnaire
A digital questionnaire (supplement) was sent to all subjects. Non response was followed by a second emailing. Finally, the professionals were approached by means of a letter and questionnaire on paper by regular post. The questionnaire was developed by an expert panel, consisting of two hospital pharmacists, an internist, a nursing home physician and a neuropsychiatrist. The survey involved questions regarding a number of characteristics of the physicians and the concrete process of medication reviewing, i.e. the accessibility of information in relation to medication reviews, which care providers are included in the review, the process of prescribing and distribution of medication, time management, possible consequences of the medication review and the actual workability of a medication review. For usability the initial questionnaire was scrutinized by peers after whom questions were deleted or refined. Data were analysed using the software IBM SPSS statistics 21. Values are presented as median values and interquartile range because of non-normal distribution. Correlation between frequency of reviewing and time spent on one medication review was calculated with the Pearson's correlation coefficient.
Results
Characteristics of subjects
Of the 134 subjects who received a questionnaire, 63 (47%) responded. Of these 63 subjects, eighteen (29%) were general practitioners and 45 (71%) nursing home physicians. The median (interquartile range) level of experience of nursing home physicians was 14 (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) years while the general practitioners had 13 (9-21) years' experience ( Table 1 ). The median number of old people under the care of nursing home physicians was 60 (40-80). For general practitioners this was 50 (20-70). All nursing home physicians worked in a team. Three out of 18 general practitioners had a solo practice.
Process of medication reviewing
All physicians reported that they performed medication reviews. The frequency with which they performed reviews ranged from daily (8%) to once a year (5%). Most of the reviews were said to be done four times a year (50%) by the general practitioners and monthly (40%) by the nursing home physicians. The frequency of reviewing did not seem to influence the time spent on one review. The median number of patients reviewed per year was reported to be 85 (50-200) for the nursing home physicians and 30 for the general practitioners. The medication reviews were mostly performed by the physician (84%) alone. In 91% of cases, regular meetings between pharmacist and physician took place, but the frequency varied from weekly to yearly. Most of the nursing home physicians said to have monthly meetings (63%) whereas most of the general practitioners had a meeting with the pharmacist four times a year (60%). These meetings were organised as pharmacotherapy audit meetings (FTOs) in 69% in both groups. In 14% of nursing home physicians and 31% of general practitioners, these meetings were arranged as medication review meetings and 7% of nursing home physicians did both. 10% of nursing home physicians also reported had other forms of consultations with the pharmacist such as by telephone. In the nursing homes, 40% of the patients are alleged to have been participating in the review whereas in the general practitioners practices 28% of the patients participated in the review. The physicians considered the doctor (86%) or the pharmacist (90%) the best professional to carry out the medication review, preferably together.
Median time spent on a review reported for one patient was 10 minutes (5-14) for nursing home physicians and 20 minutes (13-30) for general practitioners. The median number of interventions proposed after a review was 2 (1-2) and was the same in both groups. The median number of executed interventions was said to be 1 (1-2). The most important interventions mentioned were discontinuing medication and altering dosages. Seventy-three per cent of the physicians only reviewed their own patients. Fifty-nine percent of nursing home physicians and 89% of general practitioners considered workload to be a limiting factor in performing reviews.
With regard to what type of information was used when reviewing, 88% said to use laboratory values and 75% said to use patient characteristics to decide whether to start, stop or alter medication.
In case medication was changed by another doctor, for instance by a hospital specialist, 47% of the nursing home physicians and 44% the general practitioners reported to be informed often and 40% respectively 50% were informed sometimes. On the other hand 13% of nursing home physicians and 6% of general practitioners said they never received any notice of colleagues regarding medication alterations. Of nursing home physicians, 84% reported always to notify the pharmacy when altering drugs compared to 65% of general practitioners. No notification was sent in 9% and 24 respectively and in 7% of nursing home physicians and 12% of general practitioners a notification was sent sometimes.
A medication distribution protocol is a document in which the responsibility and competences with regard to the distribution and administration of drugs is determined. In 96% of nursing homes and 61% of general practices such a protocol seems to be available. In the nursing homes, 62% of drugs was said to be administered by the nursing staff while 38% was self-administered. For the older general practice population, in 62% home care nurses administered the drugs and in 39% it involved self-administered medication. 76% of all nursing home physicians and 100% of general practitioners stated to use an electronic medication surveillance program.
In 84% of nursing homes and in 50% of general practices there was said to be a drug formulary available, which was lacking in 16 and 11% respectively. Of the general practitioners, 39% did not know if there was one. In 96% of nursing homes and 56% of general practices there seem to be a treatment protocol available, it was lacking in 2% and 17% respectively, and 2% of nursing home physicians and 28% of general practitioners did not know.
None of the nursing home physicians, general practitioners or pharmacist shaves reported to be financially compensated for performing a medication review. All nursing home physicians, general practitioners and pharmacists stated to consider medication reviewing to be economically valuable and contributing to good quality of care.
Discussion
Performing proper medication reviews for multi-morbid older people is a challenging but essential process to prevent medicationrelated morbidity and adverse events. This study showed that there was substantial inconsistency in the frequency of reviewing, ranging from monthly (in 40%) by the nursing home physicians to four times a year (in 50%) by the general practitioners. In addition, the minimum requirement of reviewing every patient annually for communitydwelling patients or twice a year for nursing home residents was not met in daily practice.
Although there is consensus about the need to perform regular reviews, there is a lack of agreement about what a medication review should comprise. For example, there is no consensus on the best frequency in which a medication review should be performed, who the best professional is to carry out medication reviews and so on. Apart from this national discussion there is much heterogeneity between countries in and outside Europe in how medication reviewing should be managed. In the US for instance, pharmacists are obligated to review their nursing home patients once a month [14] . For community dwelling patients, a service model called Medication Therapy Management (MTM) is developed for older patients who meet certain criteria such as transition of care, prescription of five or more medications or a patient who has one or more chronic diseases. MTM consists of five elements, medication therapy review, personal medication record, medicationrelated action plan, intervention or referral, documentation and followup [15] . In Australia, the Department of Health and Aging published revised guiding principles for medication management in residential homes in 2012. Residential homes in Australia are obligated to have Medication Advisory Committees that monitors the medication management process. This committee comprises representatives of the management, nurses, medical practitioners and pharmacists and they will meet on a regular basis [16] . In the community, other Medication Management Review (MMR) programs are required such as the Home Medicine Review which involves the pharmacist visiting the individual at home, reviews their medicine regime and reports back to the general practitioner [17] .
Despite our best efforts, still significant improvements could be made. In 2011 the British Geriatrics Society published a report in which they also reflected on medication management. They concluded that medication management in the UK care homes could be improved and they recommended to carry out regular medication reviews to reduce medication error, however without stating the frequency [6] . In the Netherlands, the Dutch Health Care Inspectorate published a critical report in 2010 in which they concluded that improvement of medication safety was necessary in more than 75% of the investigated nursing homes and in almost 100% of the homes for the elderly [13] . The main conclusions were that the physician and nursing staff did not always have an up to date medication overview, the professionals did not perform a medication review once (community) or twice (nursing home) a year. In the homes for the elderly the nursing staff often did not know whether the patient was capable to manage his own medication. Furthermore medication signalling, for example regarding interactions or dosage adjustment advices, was not handled in time and there was no clear case manager regarding pharmaceutical care [13] .
Time spent on one review varied significantly between both groups, namely 10 minutes for a nursing home physician and 20 minutes for general practitioners. This difference in invested time might be explained by the fact that nursing home physicians care for different types of patients than the general practitioner. Also, this difference could be a reflection of the fact that medication reviews are performed differently by nursing home physicians and general practitioners. There was no significant correlation between the frequency of reviewing and time spent on one medication review. However, to the best of our knowledge there are no data on this and further investigation of this issue is needed.
The report of the Dutch Health Care Inspectorate also states that the reviews should be performed by the physician and pharmacist, nursing staff and/or patient [13] . In daily practice, meetings between the physician and pharmacist indeed took place regularly (91%), but these were mainly organised as pharmacotherapy audit meetings and not for medication reviewing of individual patients.
In addition, this study showed that the medication data transmission between professionals could be improved. When medication was changed by another doctor, e.g. by a hospital specialist, only 47% of nursing home physicians and 44% of the general practitioners were informed often and even 13% of nursing home physicians and 6% of general practitioners never received any notice. Seventy-seven per cent of the physicians themselves always notified the pharmacy when stopping drugs and 5% never did this. In daily practice, it is often difficult to establish who is primarily responsible for an up-to-date medication plan of an individual patient. Older people often have many drugs prescribed by different doctors. As a result, many physicians are involved in the treatment of one individual patient. This may lead to the feeling of not being responsible or incompetency regarding altering medications prescribed by a colleague [18] . In our opinion, the nursing home physician and general practitioner should be considered as the case-manager for their patients regarding pharmaceutical care.
With regard to what kind of information was used when reviewing, 88% used laboratory values and 75% used patient characteristics such as height and length. In daily practice, different professionals use different information sources in performing a review. For instance, a pharmacist only has access to the medication list, name and age of a patient whereas a general practitioner implements the medical history and laboratory results. Until now, there are no data about which data are important to perform a good review. Future research on this subject is needed to optimise the quality of medication reviews.
An alarming finding of our study was that 59% of the nursing home physicians and 89% of general practitioners considered workload to be an important limiting factor in performing reviews. This is an important finding which suggests that, however plausible, the recommendations made by the Dutch Health Care Inspectorate to perform a medication review for every patient once or twice a year, may not be achievable in the current situation [13] . Several studies in different settings have been performed in an attempt to guide, improve and assist the physician in performing medication reviews [19] [20] [21] . These studies have looked at educating professionals, development of computerised decision making systems, clinical pharmacy interventions, multidisciplinary approaches and combinations. These studies have shown mixed results, which leads to even more uncertainties about which review method is superior and achievable for daily practice.
The results of this survey imply that development of a novel and different medication surveillance system that is easy to use, does not add to, or even decreases the workload and can act on a continuous basis may help doctors in performing medication reviews.
This survey was limited in that the participants were only recruited in the south of the Netherlands and may therefore not be representative for other areas. Also the number of participants is small, especially the general practitioners group. Another limitation is that the results are self-reported and not objectively measured. Subsequently the interviewees may show a natural tendency to project a more positive image because they may be more committed in performing medication reviews.
To conclude, this survey shows great inconsistency in the way medication reviews are done. The results reflect how professionals define medication review themselves, which deviates on many aspects from the national recommendations. Collaboration with the pharmacist and other colleagues is thought to be important but requires improvement. Work load was said to be a major limitation in performing medication reviews which means that the minimum advices in the report of the Dutch Health Care Inspectorate in the current situation may not be attainable. This means that, to achieve a high standard, we may have to reconsider the way medication reviews are done.
